Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways
Author(s) -
Junji Matsui
Publication year - 2016
Publication title -
global journal of cancer therapy
Language(s) - English
Resource type - Journals
ISSN - 2581-5407
DOI - 10.17352/gjct.000009
Subject(s) - lenvatinib , publishing , angiogenesis , vegf receptors , cancer therapy , medicine , scientific publishing , cancer , cancer research , oncology , political science , thyroid cancer , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom